IP Library › Granted Patent US 11,603,515
Granted Patent B2
US 11,603,515 · App. 16/499,649 · Granted Mar 14, 2023

Cell culture substrate, cancer cell aggregate and method for manufacturing same using said substrate, and drug screening method using said cancer cell aggregate

Inventors: Yukiko Miyatake (Sapporo, JP); Kaori Shigetomi (Sapporo, JP); Takaharu Okajima (Sapporo, JP); Masanori Kasahara (Sapporo, JP)
Assignee: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
C12M25/06C12N5/0693G01N33/5011C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,603,515
App. No.
16/499,649
Granted
Mar 14, 2023
Kind
B2
Abstract

[Problem] An object of the present invention is to produce cancer cell clusters with intrinsic biological properties as cancer tissues, such as morphological polarity and tissue motion polarity, in vitro. [Solution] The present invention relates to a cell culture substrate including a base material and a biocompatible polymer layer, the substrate including a plurality of rough sections on the surface of the substrate, wherein the rough sections are not covered with the biocompatible polymer layer, have a predetermined surface structure with a predetermined shape, and are disposed at predetermined intervals. With the present invention, it is possible to obtain a live cancer cell aggregate having morphological polarity and tissue motion polarity similar to that observed in vivo, by a very easy operation of culturing cancer cells on a cell culture substrate having a predetermined structure, thereby performing live imaging of microtumors in vitro is enabled, which has been conventionally impossible. Moreover, since such a cancer cell aggregate is considered to reproduce a series of flow of development, proliferation, infiltration, metastasis, and recurrence of cancer in vivo, the cancer cell aggregate can be utilized as a research tool in cancer research, or for screening for an anticancer drug.

Claims (17)

1. A cell culture substrate, comprising:

a base material having a plurality of rough sections; and

a biocompatible polymer layer covering the base material such that the plurality of rough sections is exposed on a surface of the cell culture substrate,

wherein

each of the rough sections has a shape of a spot with a diameter ranging from 20 μm to 100 μm, or a groove with a width ranging from 3 μm to 30 μm, when the shape of the rough section is a groove, an end part of the rough section is optionally connected to another rough section,

a distance between two adjacent rough sections is at least 10 μm or more, and the rough section has at least one uneven structure with a height ranging from 20 nm to 200 nm on the surface.

2. The cell culture substrate according to claim 1 , wherein the rough section has a developed interfacial area ratio (Sdr) of 0.002 or more.

3. The cell culture substrate according to claim 1 , wherein the distance between the two adjacent rough sections ranges from 10 to 1,200 μm.

4. The cell culture substrate according to claim 1 , wherein the rough section has an arithmetic mean roughness (Ra) of 4 nm or more, a maximum height roughness (Rz) of 30 nm or more, and/or an arithmetic mean peak curvature (Spc) of 300 or more.

5. The cell culture substrate according to claim 1 , wherein the biocompatible polymer is an amphiphilic polymer that inhibits non-specific adsorption to a biological material.

6. The cell culture substrate according to claim 5 , wherein the amphiphilic polymer is 2-methacryloyloxyethyl phosphorylcholine.

7. The cell culture substrate according to claim 5 , wherein the amphiphilic polymer is selected from the group consisting of dimethyl polysiloxane, polyethylene glycol, oligoethylene glycol and 2-methacryloyloxyethyl phosphorylcholine.

8. The cell culture substrate according to claim 1 , wherein the rough section has an arithmetic mean roughness (Ra) of 4 nm or more.

9. The cell culture substrate according to claim 1 , wherein the rough section has a maximum height roughness (Rz) of 30 nm or more.

10. The cell culture substrate according to claim 1 , wherein the rough section has an arithmetic mean peak curvature (Spc) of 300 or more.

11. The cell culture substrate according to claim 1 , wherein the height of the uneven structure ranges from 30 nm to 100 nm.

12. The cell culture substrate according to claim 1 , wherein the height of the uneven structure ranges from 40 nm to 60 nm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2019
From: MIYATAKE, YUKIKO; SHIGETOMI, KAORI; OKAJIMA, TAKAHARU; KASAHARA, MASANORI
To: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
Reel/Frame 050567/0660 →
Priority Claims (1)
JP JP2017-072512 · Mar 31, 2017 · national
Continuity (1)
Related Publication 20200063083A1 · Feb 27, 2020